Literature DB >> 18768193

The cold adapted and temperature sensitive influenza A/Ann Arbor/6/60 virus, the master donor virus for live attenuated influenza vaccines, has multiple defects in replication at the restrictive temperature.

Winnie Chan1, Helen Zhou, George Kemble, Hong Jin.   

Abstract

We have previously determined that the temperature sensitive (ts) and attenuated (att) phenotypes of the cold adapted influenza A/Ann Arbor/6/60 strain (MDV-A), the master donor virus for the live attenuated influenza A vaccines (FluMist), are specified by the five amino acids in the PB1, PB2 and NP gene segments. To understand how these loci control the ts phenotype of MDV-A, replication of MDV-A at the non-permissive temperature (39 degrees C) was compared with recombinant wild-type A/Ann Arbor/6/60 (rWt). The mRNA and protein synthesis of MDV-A in the infected MDCK cells were not significantly reduced at 39 degrees C during a single-step replication, however, vRNA synthesis was reduced and the nuclear-cytoplasmic export of viral RNP (vRNP) was blocked. In addition, the virions released from MDV-A infected cells at 39 degrees C exhibited irregular morphology and had a greatly reduced amount of the M1 protein incorporated. The reduced M1 protein incorporation and vRNP export blockage correlated well with the virus ts phenotype because these defects could be partially alleviated by removing the three ts loci from the PB1 gene. The virions and vRNPs isolated from the MDV-A infected cells contained a higher level of heat shock protein 70 (Hsp70) than those of rWt, however, whether Hsp70 is involved in thermal inhibition of MDV-A replication remains to be determined. Our studies demonstrate that restrictive replication of MDV-A at the non-permissive temperature occurs in multiple steps of the virus replication cycle.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18768193     DOI: 10.1016/j.virol.2008.07.027

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  38 in total

1.  Evaluation of a temperature-restricted, mucosal tuberculosis vaccine in guinea pigs.

Authors:  Tuhina Gupta; Monica LaGatta; Shelly Helms; Rebecca L Pavlicek; Simon O Owino; Kaori Sakamoto; Tamas Nagy; Stephen B Harvey; Mark Papania; Stephanie Ledden; Kevin T Schultz; Candace McCombs; Frederick D Quinn; Russell K Karls
Journal:  Tuberculosis (Edinb)       Date:  2018-10-19       Impact factor: 3.131

2.  Interplay of PA-X and NS1 Proteins in Replication and Pathogenesis of a Temperature-Sensitive 2009 Pandemic H1N1 Influenza A Virus.

Authors:  Aitor Nogales; Laura Rodriguez; Marta L DeDiego; David J Topham; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

3.  Mucosal polyinosinic-polycytidylic acid improves protection elicited by replicating influenza vaccines via enhanced dendritic cell function and T cell immunity.

Authors:  José V Pérez-Girón; Alan Belicha-Villanueva; Ebrahim Hassan; Sergio Gómez-Medina; Jazmina L G Cruz; Anja Lüdtke; Paula Ruibal; Randy A Albrecht; Adolfo García-Sastre; César Muñoz-Fontela
Journal:  J Immunol       Date:  2014-06-23       Impact factor: 5.422

4.  Temperature-Sensitive Live-Attenuated Canine Influenza Virus H3N8 Vaccine.

Authors:  Aitor Nogales; Laura Rodriguez; Caroline Chauché; Kai Huang; Emma C Reilly; David J Topham; Pablo R Murcia; Colin R Parrish; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

5.  The temperature-sensitive and attenuation phenotypes conferred by mutations in the influenza virus PB2, PB1, and NP genes are influenced by the species of origin of the PB2 gene in reassortant viruses derived from influenza A/California/07/2009 and A/WSN/33 viruses.

Authors:  Andrew J Broadbent; Celia P Santos; Rachel A Godbout; Kanta Subbarao
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

6.  Alternative live-attenuated influenza vaccines based on modifications in the polymerase genes protect against epidemic and pandemic flu.

Authors:  Alicia Solórzano; Jianqiang Ye; Daniel R Pérez
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

Review 7.  Human body temperature and new approaches to constructing temperature-sensitive bacterial vaccines.

Authors:  Matthew D White; Catharine M Bosio; Barry N Duplantis; Francis E Nano
Journal:  Cell Mol Life Sci       Date:  2011-05-31       Impact factor: 9.261

8.  Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell cultures.

Authors:  William A Fischer; Kelly D Chason; Missy Brighton; Ilona Jaspers
Journal:  Vaccine       Date:  2014-01-30       Impact factor: 3.641

9.  Development of an RNA Strand-Specific Hybridization Assay To Differentiate Replicating versus Nonreplicating Influenza A Viruses.

Authors:  Genyan Yang; Erin N Hodges; Jörn Winter; Natosha Zanders; Svetlana Shcherbik; Tatiana Bousse; Janna R Murray; A K M Muraduzzaman; Mahbubur Rahman; A S M Alamgir; Meerjady Sabrina Flora; Lenee Blanton; John R Barnes; David E Wentworth; C Todd Davis
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

10.  The effect of season on inflammatory response in captive baboons.

Authors:  Dianne McFarlane; Roman F Wolf; Kristen A McDaniel; Gary L White
Journal:  J Med Primatol       Date:  2012-08-21       Impact factor: 0.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.